Which is more valuable in the follow-up and evaluation of stable COPD cases; CRP or Eosinophil or Leukocyte?

Author:

BOZKURT Nurgül1,BOZKURT Ali İhsan2

Affiliation:

1. AKDENİZ ÜNİVERSİTESİ

2. PAMUKKALE ÜNİVERSİTESİ

Abstract

Objective:COPD(Chronic obstructive pulmonary disease) is a disease characterized by chronic inflammation with exacerbations.It is known that inflammatory markers such as CRP(C-reactive protein), eosinophils and leukocytes can be variable in exacerbations of COPD and should be followed-up.In this study,the relationships of CRP, eosinophil, leukocyte levels with the number of exacerbations/prognosis were investigated in COPDpatients. Methods:Data from stable COPD patients were analyzed in the study. CRP, eosinophil and leukocyte levels were measured. PFT was performed, CAT(COPD Assesment Test), m-MRC(Modified Medical Research Council) scores were calculated. The relationships between the number of exacerbations, CAT and m-MRC scores and CRP, eosinophil and leukocyte levels of the patients were evaluated. Correlation analysis, ANOVA and X2 tests were used in the analyses. Results:The mean age of the stable 151 COPD patients was 66.1 years and 84.8% were male. The annual number of exacerbations is 1.9±5.1. Eosinophil level was found to be high in 9.9% of cases, this rate was 4.7% for CRP. Leukocyte level was found to be high in 20.5% of cases. The correlations between the CRP,eosinophil and leukocyte levels and the m-MRC, CAT score, GOLD(Global Initiative for Chronic Obstructive Lung Disease) classification, the number of exacerbations were examined. There was no significant correlation between CRP and eosinophil levels and these parameters. Positively, significant correlation was found between leukocyte level and both m-MRC, CAT scores and number of exacerbations. Similarly, it was found that the proportion of patients with "high leukocyte levels" increased in patients with high number of exacerbations, m-MRC and CAT scores(p

Publisher

Akdeniz University

Reference22 articles.

1. 1. Kocabaş A. Kronik Obstrüktif Akciğer Hastalığı Epidemiyolojisi Ve Risk Faktorleri. TTD Toraks Cerrahisi Bülteni 2010;1(2):106-113.

2. 2. Tanım ve Epidemiyoloji, Hastalık Gelişimi ve İlerlemesine Etkili Faktörler, Patoloji, Patogenez, Fizyopatoloji (Türk Toraks Derneği’nin Gold 2021 Kronik Obstrüktif Akciğer Hastalığı (Koah) Raporuna Bakışı), 2021:1-16.

3. 3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2021 Report. http:// goldcopd.org (Erişim tarihi: 12 Temmuz 2021).

4. 4. Esteban C, Quintana JM, Moraza J, Aburto M, Egurrola M, España PP, Pérez-Izquierdo J, Aguirre U, Aizpiri S, Capelastegui A. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med 2009;103(8):1201–1208.

5. 5. Müllerova H, Maselli DJ, Locantore N, Vestbo J, Hurst JR, Wedzicha JA, Bakke P, Agusti A, Anzueto A. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest 2015;147(4):999–1007.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3